Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio

Background and Objectives: Triple-negative breast cancer (TNBC), a highly aggressive and heterogeneous subtype of breast cancer, accounts for ap-proximately 10–15% of all breast cancer cases. Currently, there is no effective therapeutic target for TNBC. Tu-mor-associated macrophages (TAMs), which ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jianyu, Deng, Yuhan, Liu, Zhuolin, Li, Xue, Zhang, Mingxuan, Yu, Xin, Liu, Tong, Chen, Kexin, Li, Zhigao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386704/
https://www.ncbi.nlm.nih.gov/pubmed/37512096
http://dx.doi.org/10.3390/medicina59071285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386704/
https://www.ncbi.nlm.nih.gov/pubmed/37512096
http://dx.doi.org/10.3390/medicina59071285

Ejemplares similares